Key result
Prothrombin complex concentrates used for the reversal of vitamin K antagonists carry potential risks that require careful clinical assessment.
Key points are not available for this paper at this time.
Calls for careful PCC selection in VKA reversal; leaves open comparative safety data from prospective studies.
No takes yet. Share an insight, caveat, or question.
Michael B. Streiff (2011) studied this question. Prothrombin complex concentrates used for the reversal of vitamin K antagonists carry potential risks that require careful clinical assessment.